Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Why a Gamble on AmBev Stock Makes Sense

By Josh Enomoto, InvestorPlace Contributor Jul 29, 2019

Over the past year, AmBev stock became one of the ugliest names on Wall Street. However, the last Q2 earnings report confirms that positive fundamentals in the Latin American market support the case for a recovery.

3 Reasons to Tune Out of iQiyi Stock for Now

By Josh Enomoto, InvestorPlace Contributor Jul 26, 2019

Despite the moniker of China’s Netflix, IQ stock has largely disappointed stakeholders. But even with its currently deflated price, the fundamentals don’t convincingly justify a big move up.

TSLA Stock Might Need a Tow Truck

By Josh Enomoto, InvestorPlace Contributor Jul 26, 2019

After missing earnings and revenue expectations for Q2, Wall Street wasted no time dumping TSLA stock. While the reasoning is suspect, the dumping itself is justified because Tesla faces an extraordinary magnitude of competition, as well as uncontrollable economic headwinds.

3 Reasons to Place Your Bet on GE Stock

By Josh Enomoto, InvestorPlace Contributor Jul 25, 2019

Rightfully, GE stock absorbed a pummeling from Wall Street. But with the dust settled, there are some positive drivers here for gamblers.

Why You Can Trust ACB Stock Despite This Dip

By Josh Enomoto, InvestorPlace Contributor Jul 25, 2019

Admittedly, the fallout in ACB stock is incredibly ugly. However, panicking is not the best course of action due to Aurora Cannabis’ longer-term fundamental drivers.